| Year |
Citation |
Score |
| 2020 |
Chuckran CA, Liu C, Bruno TC, Workman CJ, Vignali DA. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy. Journal For Immunotherapy of Cancer. 8. PMID 32675311 DOI: 10.1136/Jitc-2020-000967 |
0.48 |
|
| 2019 |
Liu B, Hood JD, Kolawole EM, Woodruff DM, Vignali DA, Bettini M, Evavold BD. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery. Diabetes. PMID 31806623 DOI: 10.2337/Db19-0399 |
0.371 |
|
| 2016 |
Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA. Interleukin-35 Limits Anti-Tumor Immunity. Immunity. 44: 316-29. PMID 26872697 DOI: 10.1016/J.Immuni.2016.01.013 |
0.377 |
|
| 2016 |
Liu C, Workman CJ, Vignali DA. Targeting Regulatory T Cells in Tumors. The Febs Journal. PMID 26787424 DOI: 10.1111/febs.13656 |
0.339 |
|
| 2016 |
Overacre AE, Vignali DA. T(reg) stability: to be or not to be. Current Opinion in Immunology. 39: 39-43. PMID 26774863 DOI: 10.1016/j.coi.2015.12.009 |
0.32 |
|
| 2015 |
Turnis ME, Andrews LP, Vignali DA. Inhibitory receptors as targets for cancer immunotherapy. European Journal of Immunology. 45: 1892-905. PMID 26018646 DOI: 10.1002/eji.201344413 |
0.35 |
|
| 2014 |
Ito Y, Hashimoto M, Hirota K, Ohkura N, Morikawa H, Nishikawa H, Tanaka A, Furu M, Ito H, Fujii T, Nomura T, Yamazaki S, Morita A, Vignali DA, Kappler JW, et al. Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease. Science (New York, N.Y.). 346: 363-8. PMID 25324392 DOI: 10.1126/science.1259077 |
0.384 |
|
| 2014 |
Jha V, Workman CJ, McGaha TL, Li L, Vas J, Vignali DA, Monestier M. Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity. Plos One. 9: e104484. PMID 25122007 DOI: 10.1371/Journal.Pone.0104484 |
0.321 |
|
| 2014 |
Bettini M, Blanchfield L, Castellaw A, Zhang Q, Nakayama M, Smeltzer MP, Zhang H, Hogquist KA, Evavold BD, Vignali DA. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential. Journal of Immunology (Baltimore, Md. : 1950). 193: 571-9. PMID 24943217 DOI: 10.4049/Jimmunol.1400043 |
0.398 |
|
| 2014 |
Bettini ML, Guy C, Dash P, Vignali KM, Hamm DE, Dobbins J, Gagnon E, Thomas PG, Wucherpfennig KW, Vignali DA. Membrane association of the CD3ε signaling domain is required for optimal T cell development and function. Journal of Immunology (Baltimore, Md. : 1950). 193: 258-67. PMID 24899501 DOI: 10.4049/Jimmunol.1400322 |
0.366 |
|
| 2014 |
Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunological Reviews. 259: 173-91. PMID 24712466 DOI: 10.1111/Imr.12173 |
0.303 |
|
| 2014 |
Hoseini SS, Hapke M, Herbst J, Wedekind D, Baumann R, Krueger A, Heinz N, Schiedlmeier B, Vignali D, van den Brink MR, Schambach A, Blazar BR, Sauer MG. Timely Controlled T Cell Receptor Expression of Genetically Engineered Precursor T Cells Requires Early Transgene Induction for Leukemia Control after Hematopoietic Stem Cell Transplantation Blood. 124: 657-657. DOI: 10.1182/Blood.V124.21.657.657 |
0.422 |
|
| 2013 |
Shi LZ, Kalupahana NS, Turnis ME, Neale G, Hock H, Vignali DA, Chi H. Inhibitory role of the transcription repressor Gfi1 in the generation of thymus-derived regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 110: E3198-205. PMID 23918371 DOI: 10.1073/Pnas.1300950110 |
0.425 |
|
| 2013 |
Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA. Retraction. Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. Journal of Immunology (Baltimore, Md. : 1950). 191: 2018. PMID 23913974 DOI: 10.4049/Jimmunol.1390040 |
0.361 |
|
| 2013 |
Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J, Workman CJ, Vignali DA. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature. 501: 252-6. PMID 23913274 DOI: 10.1038/Nature12428 |
0.345 |
|
| 2013 |
Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nature Reviews. Immunology. 13: 461-7. PMID 23681097 DOI: 10.1038/Nri3464 |
0.419 |
|
| 2013 |
Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, Jiang S, Kuchroo VK, Mathis D, Roncarolo MG, Rudensky A, Sakaguchi S, Shevach EM, Vignali DA, Ziegler SF. Regulatory T cells: recommendations to simplify the nomenclature. Nature Immunology. 14: 307-8. PMID 23507634 DOI: 10.1038/Ni.2554 |
0.4 |
|
| 2013 |
Guy CS, Vignali KM, Temirov J, Bettini ML, Overacre AE, Smeltzer M, Zhang H, Huppa JB, Tsai YH, Lobry C, Xie J, Dempsey PJ, Crawford HC, Aifantis I, Davis MM, ... Vignali DA, et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology. 14: 262-70. PMID 23377202 DOI: 10.1038/Ni.2538 |
0.326 |
|
| 2012 |
Delgoffe GM, Bettini ML, Vignali DA. Identity crisis: it's not just Foxp3 anymore. Immunity. 37: 759-61. PMID 23159220 DOI: 10.1016/J.Immuni.2012.10.012 |
0.34 |
|
| 2012 |
Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. Journal of Immunology (Baltimore, Md. : 1950). 189: 5590-601. PMID 23152566 DOI: 10.4049/Jimmunol.1201744 |
0.381 |
|
| 2012 |
Do JS, Valujskikh A, Vignali DA, Fairchild RL, Min B. Unexpected role for MHC II-peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo. Proceedings of the National Academy of Sciences of the United States of America. 109: 12698-703. PMID 22802622 DOI: 10.1073/Pnas.1207219109 |
0.397 |
|
| 2012 |
Delmastro MM, Styche AJ, Trucco MM, Workman CJ, Vignali DA, Piganelli JD. Modulation of redox balance leaves murine diabetogenic TH1 T cells "LAG-3-ing" behind. Diabetes. 61: 1760-8. PMID 22586584 DOI: 10.2337/db11-1591 |
0.366 |
|
| 2012 |
Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, Floess S, Bell BD, Ziegler SF, Huehn J, Pardoll DM, Vignali DA. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity. 36: 717-30. PMID 22579476 DOI: 10.1016/J.Immuni.2012.03.020 |
0.335 |
|
| 2012 |
Bettini ML, Bettini M, Vignali DA. T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice. Immunology. 136: 265-72. PMID 22348644 DOI: 10.1111/J.1365-2567.2012.03574.X |
0.405 |
|
| 2012 |
Gravano DM, Vignali DA. The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cellular and Molecular Life Sciences : Cmls. 69: 1997-2008. PMID 22205213 DOI: 10.1007/s00018-011-0907-z |
0.394 |
|
| 2012 |
Dixon K, Kooij Sd, Schlagwein N, Vignali DA, Kooten Cv. O038 Role of human tolerogenic dendritic cell derived IL-35 in regulating T cell responses Cytokine. 59: 515-515. DOI: 10.1016/J.Cyto.2012.06.075 |
0.346 |
|
| 2011 |
Pillai MR, Collison LW, Wang X, Finkelstein D, Rehg JE, Boyd K, Szymczak-Workman AL, Doggett T, Griffith TS, Ferguson TA, Vignali DA. The plasticity of regulatory T cell function. Journal of Immunology (Baltimore, Md. : 1950). 187: 4987-97. PMID 22013112 DOI: 10.4049/Jimmunol.1102173 |
0.341 |
|
| 2011 |
Szymczak-Workman AL, Delgoffe GM, Green DR, Vignali DA. Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. Journal of Immunology (Baltimore, Md. : 1950). 187: 4416-20. PMID 21949016 DOI: 10.4049/Jimmunol.1100548 |
0.343 |
|
| 2011 |
Day EB, Guillonneau C, Gras S, La Gruta NL, Vignali DA, Doherty PC, Purcell AW, Rossjohn J, Turner SJ. Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses. Proceedings of the National Academy of Sciences of the United States of America. 108: 9536-41. PMID 21606376 DOI: 10.1073/Pnas.1106851108 |
0.3 |
|
| 2011 |
Viret C, Leung-Theung-Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S. Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. The Journal of Clinical Investigation. 121: 1810-21. PMID 21505262 DOI: 10.1172/JCI43314 |
0.376 |
|
| 2011 |
Lucas CL, Workman CJ, Beyaz S, LoCascio S, Zhao G, Vignali DA, Sykes M. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood. 117: 5532-40. PMID 21422469 DOI: 10.1182/Blood-2010-11-318675 |
0.359 |
|
| 2011 |
Workman CJ, Collison LW, Bettini M, Pillai MR, Rehg JE, Vignali DA. In vivo Treg suppression assays. Methods in Molecular Biology (Clifton, N.J.). 707: 119-56. PMID 21287333 DOI: 10.1007/978-1-61737-979-6_9 |
0.332 |
|
| 2011 |
Koestner W, Hapke M, Herbst J, Klein C, Welte K, Fruehauf J, Flatley A, Vignali DA, Hardtke-Wolenski M, Jaeckel E, Blazar BR, Sauer MG. PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells. Blood. 117: 1030-41. PMID 21063028 DOI: 10.1182/Blood-2010-04-283119 |
0.448 |
|
| 2011 |
Goldberg MV, Woo S, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Vogel P, Grosso JF, Netto G, Chaux A, Smeltzer M, Workman CJ, Pardoll DM, Korman AJ, Vignali DA, et al. Abstract LB-251: The checkpoint molecules LAG-3 and PD-1 synergize to maintain tolerance to tumors Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-251 |
0.321 |
|
| 2010 |
Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, ... Vignali DA, et al. IL-35-mediated induction of a potent regulatory T cell population. Nature Immunology. 11: 1093-101. PMID 20953201 DOI: 10.1038/Ni.1952 |
0.367 |
|
| 2010 |
Woo SR, Li N, Bruno TC, Forbes K, Brown S, Workman C, Drake CG, Vignali DA. Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4. European Journal of Immunology. 40: 1768-77. PMID 20391435 DOI: 10.1002/Eji.200939874 |
0.332 |
|
| 2010 |
Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, Vignali DA. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 4863-70. PMID 20348424 DOI: 10.4049/Jimmunol.0903728 |
0.376 |
|
| 2010 |
Wang H, Holst J, Woo SR, Guy C, Bettini M, Wang Y, Shafer A, Naramura M, Mingueneau M, Dragone LL, Hayes SM, Malissen B, Band H, Vignali DA. Tonic ubiquitylation controls T-cell receptor:CD3 complex expression during T-cell development. The Embo Journal. 29: 1285-98. PMID 20150895 DOI: 10.1038/Emboj.2010.10 |
0.373 |
|
| 2010 |
Bettini ML, Vignali DA. Development of thymically derived natural regulatory T cells. Annals of the New York Academy of Sciences. 1183: 1-12. PMID 20146704 DOI: 10.1111/J.1749-6632.2009.05129.X |
0.318 |
|
| 2009 |
Guy CS, Vignali DA. Organization of proximal signal initiation at the TCR:CD3 complex. Immunological Reviews. 232: 7-21. PMID 19909352 DOI: 10.1111/j.1600-065X.2009.00843.x |
0.352 |
|
| 2009 |
Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Current Opinion in Immunology. 21: 612-8. PMID 19854631 DOI: 10.1016/j.coi.2009.09.011 |
0.395 |
|
| 2009 |
Lennon GP, Bettini M, Burton AR, Vincent E, Arnold PY, Santamaria P, Vignali DA. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity. 31: 643-53. PMID 19818656 DOI: 10.1016/j.immuni.2009.07.008 |
0.409 |
|
| 2009 |
Grosso JF, Goldberg MV, Getnet D, Bruno TC, Yen HR, Pyle KJ, Hipkiss E, Vignali DA, Pardoll DM, Drake CG. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 6659-69. PMID 19454660 DOI: 10.4049/Jimmunol.0804211 |
0.345 |
|
| 2009 |
Collison LW, Pillai MR, Chaturvedi V, Vignali DA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. Journal of Immunology (Baltimore, Md. : 1950). 182: 6121-8. PMID 19414764 DOI: 10.4049/Jimmunol.0803646 |
0.382 |
|
| 2009 |
Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. The development and function of regulatory T cells. Cellular and Molecular Life Sciences : Cmls. 66: 2603-22. PMID 19390784 DOI: 10.1007/S00018-009-0026-2 |
0.431 |
|
| 2009 |
Szymczak-Workman AL, Workman CJ, Vignali DA. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. Journal of Immunology (Baltimore, Md. : 1950). 182: 5188-92. PMID 19380762 DOI: 10.4049/jimmunol.0803123 |
0.389 |
|
| 2009 |
Workman CJ, Wang Y, El Kasmi KC, Pardoll DM, Murray PJ, Drake CG, Vignali DA. LAG-3 regulates plasmacytoid dendritic cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 182: 1885-91. PMID 19201841 DOI: 10.4049/Jimmunol.0800185 |
0.431 |
|
| 2009 |
Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunology. 10: 29-37. PMID 19043418 DOI: 10.1038/Ni.1679 |
0.389 |
|
| 2009 |
Nakayama M, Castoe T, Jasinski J, He X, Johnson K, Haskins K, Pollock D, Vignali D, Eisenbarth G. OR.66. Pathogenic T Cell Receptor Valpha Germline Sequence Targeting Primary Peptide Insulin B:9-23 Clinical Immunology. 131: S28. DOI: 10.1016/J.Clim.2009.03.078 |
0.333 |
|
| 2008 |
Vogtenhuber C, O'Shaughnessy MJ, Vignali DA, Blazar BR. Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo. Journal of Immunology (Baltimore, Md. : 1950). 181: 8767-75. PMID 19050298 DOI: 10.4049/Jimmunol.181.12.8767 |
0.326 |
|
| 2008 |
Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nature Reviews. Immunology. 8: 523-32. PMID 18566595 DOI: 10.1038/Nri2343 |
0.406 |
|
| 2008 |
Tailor P, Tsai S, Shameli A, Serra P, Wang J, Robbins S, Nagata M, Szymczak-Workman AL, Vignali DA, Santamaria P. The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling. Journal of Immunology (Baltimore, Md. : 1950). 181: 243-55. PMID 18566390 DOI: 10.4049/Jimmunol.181.1.243 |
0.337 |
|
| 2008 |
Holst J, Wang H, Eder KD, Workman CJ, Boyd KL, Baquet Z, Singh H, Forbes K, Chruscinski A, Smeyne R, van Oers NS, Utz PJ, Vignali DA. Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nature Immunology. 9: 658-66. PMID 18469818 DOI: 10.1038/Ni.1611 |
0.35 |
|
| 2008 |
Chaparro RJ, Burton AR, Serreze DV, Vignali DA, DiLorenzo TP. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. Journal of Immunological Methods. 335: 106-15. PMID 18439618 DOI: 10.1016/J.Jim.2008.03.007 |
0.427 |
|
| 2008 |
Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L, Flores M, Li N, Schweighoffer E, Greenberg S, Tybulewicz V, Vignali D, Clynes R. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. Journal of Immunology (Baltimore, Md. : 1950). 180: 5916-26. PMID 18424711 DOI: 10.4049/Jimmunol.180.9.5916 |
0.405 |
|
| 2008 |
Vignali D. How many mechanisms do regulatory T cells need? European Journal of Immunology. 38: 908-11. PMID 18395857 DOI: 10.1002/eji.200738114 |
0.341 |
|
| 2008 |
Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes. 57: 1321-30. PMID 18299317 DOI: 10.2337/Db07-1129 |
0.37 |
|
| 2008 |
Chaparro R, Burton A, Serreze D, Vignali D, DiLorenzo T. Sa.67. Rapid Identification of MHC Class I-restricted Antigens Relevant to Autoimmune Diabetes Using Retrogenic T Cells Clinical Immunology. 127. DOI: 10.1016/J.Clim.2008.03.288 |
0.388 |
|
| 2008 |
Vignali D. Cover Picture: How many mechanisms do regulatory T cells need? – Eur. J. Immunol. 4/2008 European Journal of Immunology. 38. DOI: 10.1002/Eji.200890013 |
0.343 |
|
| 2007 |
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450: 566-9. PMID 18033300 DOI: 10.1038/Nature06306 |
0.412 |
|
| 2007 |
Li N, Wang Y, Forbes K, Vignali KM, Heale BS, Saftig P, Hartmann D, Black RA, Rossi JJ, Blobel CP, Dempsey PJ, Workman CJ, Vignali DA. Metalloproteases regulate T-cell proliferation and effector function via LAG-3. The Embo Journal. 26: 494-504. PMID 17245433 DOI: 10.1038/Sj.Emboj.7601520 |
0.422 |
|
| 2006 |
Holst J, Szymczak-Workman AL, Vignali KM, Burton AR, Workman CJ, Vignali DA. Generation of T-cell receptor retrogenic mice. Nature Protocols. 1: 406-17. PMID 17406263 DOI: 10.1038/nprot.2006.61 |
0.32 |
|
| 2006 |
Aublin A, Ciofani M, Willkomm N, Hamrouni A, Szymczak-Workman AL, Takahashi T, Sandjeu Y, Guillaume P, Vignali DA, Michielin O, Zúñiga-Pflücker JC, Maryanski JL. A natural structural variant of the mouse TCR beta-chain displays intrinsic receptor function and antigen specificity. Journal of Immunology (Baltimore, Md. : 1950). 177: 8587-94. PMID 17142757 DOI: 10.4049/Jimmunol.177.12.8587 |
0.323 |
|
| 2006 |
Holst J, Vignali KM, Burton AR, Vignali DA. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nature Methods. 3: 191-7. PMID 16489336 DOI: 10.1038/nmeth858 |
0.371 |
|
| 2005 |
Szymczak AL, Workman CJ, Gil D, Dilioglou S, Vignali KM, Palmer E, Vignali DA. The CD3epsilon proline-rich sequence, and its interaction with Nck, is not required for T cell development and function. Journal of Immunology (Baltimore, Md. : 1950). 175: 270-5. PMID 15972658 |
0.366 |
|
| 2005 |
Workman CJ, Vignali DA. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). Journal of Immunology (Baltimore, Md. : 1950). 174: 688-95. PMID 15634887 |
0.439 |
|
| 2004 |
Li N, Workman CJ, Martin SM, Vignali DA. Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). Journal of Immunology (Baltimore, Md. : 1950). 173: 6806-12. PMID 15557174 |
0.349 |
|
| 2004 |
Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA. Role of LAG-3 in regulatory T cells. Immunity. 21: 503-13. PMID 15485628 DOI: 10.1016/J.Immuni.2004.08.010 |
0.407 |
|
| 2004 |
Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, Vignali D, Piedra PA, Brenner MK, Rooney CM. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood. 104: 2432-40. PMID 15265797 DOI: 10.1182/Blood-2004-02-0646 |
0.472 |
|
| 2004 |
Workman CJ, Cauley LS, Kim IJ, Blackman MA, Woodland DL, Vignali DA. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 5450-5. PMID 15100286 DOI: 10.4049/Jimmunol.172.9.5450 |
0.427 |
|
| 2003 |
Wagner HJ, Sili U, Gahn B, Vigouroux S, Huls MH, Xie W, Vignali D, Brenner MK, Heslop HE, Rooney CM. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15. Cytotherapy. 5: 231-40. PMID 12850791 DOI: 10.1080/14653240310001262 |
0.395 |
|
| 2002 |
Arnold PY, Vignali KM, Miller TB, La Gruta NL, Cauley LS, Haynes L, Scott Adams P, Swain SL, Woodland DL, Vignali DA. Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells. Journal of Immunological Methods. 271: 137-51. PMID 12445737 DOI: 10.1016/S0022-1759(02)00343-5 |
0.329 |
|
| 2002 |
Workman CJ, Rice DS, Dugger KJ, Kurschner C, Vignali DA. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). European Journal of Immunology. 32: 2255-63. PMID 12209638 DOI: 10.1002/1521-4141(200208)32:8<2255::Aid-Immu2255>3.0.Co;2-A |
0.349 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Joseph A, Zheng JH, Follenzi A, Dilorenzo T, Sango K, Hyman J, Chen K, Piechocka-Trocha A, Brander C, Hooijberg E, Vignali DA, Walker BD, Goldstein H. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. Journal of Virology. 82: 3078-89. PMID 18184707 DOI: 10.1128/Jvi.01812-07 |
0.299 |
|
| 2015 |
He Y, Rangarajan S, Kerzic M, Luo M, Chen Y, Wang Q, Yin Y, Workman CJ, Vignali KM, Vignali DA, Mariuzza RA, Orban J. Identification of the Docking Site for CD3 on the T Cell Receptor β Chain by Solution NMR. The Journal of Biological Chemistry. PMID 26109064 DOI: 10.1074/Jbc.M115.663799 |
0.298 |
|
| 2004 |
La Gruta NL, Liu H, Dilioglou S, Rhodes M, Wiest DL, Vignali DA. Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation. Journal of Immunology (Baltimore, Md. : 1950). 172: 3662-9. PMID 15004169 |
0.296 |
|
| 2016 |
Visperas A, Vignali DA. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them? Journal of Immunology (Baltimore, Md. : 1950). 197: 3762-3770. PMID 27815439 DOI: 10.4049/jimmunol.1601118 |
0.294 |
|
| 2016 |
Tomita Y, Satomi M, Baran WB, Gan EJ, Workman AS, Workman CJ, Vignali DA, Burlingham WJ. Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade. Transplantation Direct. 2: e73. PMID 27500263 DOI: 10.1097/TXD.0000000000000580 |
0.292 |
|
| 2003 |
Clatza A, Bonifaz LC, Vignali DA, Moreno J. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. Journal of Immunology (Baltimore, Md. : 1950). 171: 6478-87. PMID 14662847 |
0.29 |
|
| 2011 |
Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. Journal of Immunology (Baltimore, Md. : 1950). 186: 6661-6. PMID 21576509 DOI: 10.4049/Jimmunol.1100315 |
0.288 |
|
| 2014 |
Delgoffe GM, Vignali DA. A Fox of a different color: FoxA1 programs a new regulatory T cell subset. Nature Medicine. 20: 236-7. PMID 24603791 DOI: 10.1038/Nm.3493 |
0.287 |
|
| 2007 |
Li N, Boyd K, Dempsey PJ, Vignali DA. Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development. Journal of Immunology (Baltimore, Md. : 1950). 178: 4214-21. PMID 17371977 |
0.287 |
|
| 2002 |
Cauley LS, Cookenham T, Miller TB, Adams PS, Vignali KM, Vignali DA, Woodland DL. Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. Journal of Immunology (Baltimore, Md. : 1950). 169: 6655-8. PMID 12471092 DOI: 10.4049/Jimmunol.169.12.6655 |
0.286 |
|
| 2012 |
Vignali DA. Mechanisms of T(reg) Suppression: Still a Long Way to Go. Frontiers in Immunology. 3: 191. PMID 22783262 DOI: 10.3389/fimmu.2012.00191 |
0.283 |
|
| 2015 |
Park AC, Huang G, Jankowska-Gan E, Massoudi D, Kernien JF, Vignali DA, Sullivan JA, Wilkes DS, Burlingham WJ, Greenspan DS. Mucosal administration of collagen V ameliorates atherosclerotic plaque burden by inducing IL-35-dependent tolerance. The Journal of Biological Chemistry. PMID 26721885 DOI: 10.1074/Jbc.M115.681882 |
0.277 |
|
| 2012 |
Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, ... ... Vignali DA, et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Research. 72: 917-27. PMID 22186141 DOI: 10.1158/0008-5472.Can-11-1620 |
0.277 |
|
| 2015 |
Sawant DV, Hamilton K, Vignali DA. Interleukin-35: Expanding Its Job Profile. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 499-512. PMID 25919641 DOI: 10.1089/Jir.2015.0015 |
0.27 |
|
| 2011 |
Collison LW, Vignali DA. In vitro Treg suppression assays. Methods in Molecular Biology (Clifton, N.J.). 707: 21-37. PMID 21287326 DOI: 10.1007/978-1-61737-979-6_2 |
0.263 |
|
| 2021 |
Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Staines B, Heaps A, Sobolewski MD, Rennick LJ, Macatangay BJC, Klamar-Blain C, Kitsios GD, Methé B, Somasundaram A, ... ... Vignali DA, et al. Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33507235 DOI: 10.1093/cid/ciab072 |
0.259 |
|
| 2011 |
Bettini M, Vignali DA. T cell-driven initiation and propagation of autoimmune diabetes. Current Opinion in Immunology. 23: 754-60. PMID 22056379 DOI: 10.1016/j.coi.2011.10.002 |
0.257 |
|
| 2012 |
Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA. The composition and signaling of the IL-35 receptor are unconventional. Nature Immunology. 13: 290-9. PMID 22306691 DOI: 10.1038/Ni.2227 |
0.252 |
|
| 2005 |
Church LD, Hessler G, Goodall JE, Rider DA, Workman CJ, Vignali DA, Bacon PA, Gulbins E, Young SP. TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx. Journal of Leukocyte Biology. 78: 266-78. PMID 15817701 DOI: 10.1189/Jlb.1003456 |
0.245 |
|
| 2014 |
Sawant DV, Gravano DM, Vogel P, Giacomin P, Artis D, Vignali DA. Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection. Journal of Immunology (Baltimore, Md. : 1950). 192: 2904-12. PMID 24532574 DOI: 10.4049/Jimmunol.1202502 |
0.244 |
|
| 2002 |
Arnold PY, La Gruta NL, Miller T, Vignali KM, Adams PS, Woodland DL, Vignali DA. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. Journal of Immunology (Baltimore, Md. : 1950). 169: 739-49. PMID 12097376 |
0.24 |
|
| 2016 |
Dobbins J, Gagnon E, Godec J, Pyrdol J, Vignali DA, Sharpe AH, Wucherpfennig KW. Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling. Science Signaling. 9: ra75. PMID 27460989 DOI: 10.1126/Scisignal.Aaf0626 |
0.223 |
|
| 2015 |
Dixon KO, van der Kooij SW, Vignali DA, van Kooten C. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. European Journal of Immunology. 45: 1736-47. PMID 25820702 DOI: 10.1002/eji.201445217 |
0.222 |
|
| 2011 |
Delgoffe GM, Murray PJ, Vignali DA. Interpreting mixed signals: the cell's cytokine conundrum. Current Opinion in Immunology. 23: 632-8. PMID 21852079 DOI: 10.1016/J.Coi.2011.07.013 |
0.213 |
|
| 2017 |
Andrews LP, Marciscano AE, Drake CG, Vignali DA. LAG3 (CD223) as a cancer immunotherapy target. Immunological Reviews. 276: 80-96. PMID 28258692 DOI: 10.1111/imr.12519 |
0.212 |
|
| 2008 |
Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunological Reviews. 226: 248-62. PMID 19161429 DOI: 10.1111/J.1600-065X.2008.00704.X |
0.209 |
|
| 2005 |
Szymczak AL, Vignali DA. Plasticity and rigidity in adaptor protein-2-mediated internalization of the TCR:CD3 complex. Journal of Immunology (Baltimore, Md. : 1950). 174: 4153-60. PMID 15778375 |
0.208 |
|
| 2012 |
Nakayama M, Castoe T, Sosinowski T, He X, Johnson K, Haskins K, Vignali DA, Gapin L, Pollock D, Eisenbarth GS. Germline TRAV5D-4 T-cell receptor sequence targets a primary insulin peptide of NOD mice. Diabetes. 61: 857-65. PMID 22315318 DOI: 10.2337/Db11-1113 |
0.207 |
|
| 2011 |
Jones LL, Vignali DA. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunologic Research. 51: 5-14. PMID 21553332 DOI: 10.1007/S12026-011-8209-Y |
0.194 |
|
| 2018 |
Burlingham W, Sullivan JA, Lema DA, Tomita Y, Zhou Y, Vignali D. The Mark of Zorro Transplantation. 102: S328-S329. DOI: 10.1097/01.Tp.0000543057.28120.C8 |
0.183 |
|
| 2020 |
Grebinoski S, Vignali DA. Inhibitory receptor agonists: the future of autoimmune disease therapeutics? Current Opinion in Immunology. 67: 1-9. PMID 32619929 DOI: 10.1016/j.coi.2020.06.001 |
0.182 |
|
| 2016 |
Zhang Q, Vignali DA. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. Immunity. 44: 1034-1051. PMID 27192568 DOI: 10.1016/j.immuni.2016.04.017 |
0.169 |
|
| 2013 |
Delgoffe GM, Vignali DA. STAT heterodimers in immunity: A mixed message or a unique signal? Jak-Stat. 2: e23060. PMID 24058793 DOI: 10.4161/jkst.23060 |
0.169 |
|
| 2006 |
El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG, Alexander W, Vignali DA, et al. General nature of the STAT3-activated anti-inflammatory response. Journal of Immunology (Baltimore, Md. : 1950). 177: 7880-8. PMID 17114459 DOI: 10.4049/Jimmunol.177.11.7880 |
0.167 |
|
| 2013 |
Bettini ML, Bettini M, Nakayama M, Guy CS, Vignali DA. Generation of T cell receptor-retrogenic mice: improved retroviral-mediated stem cell gene transfer. Nature Protocols. 8: 1837-40. PMID 24008379 DOI: 10.1038/Nprot.2013.111 |
0.165 |
|
| 2023 |
Cruz T, Agudelo Garcia PA, Chamucero-Millares JA, Bondonese A, Mitash N, Sembrat J, Tabib T, Zhang W, Seyed N, Peters V, Stacey S, Vignali D, Mora AL, Lafyatis R, Rojas M. End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity. Journal of Immunology (Baltimore, Md. : 1950). PMID 37566492 DOI: 10.4049/jimmunol.2300182 |
0.162 |
|
| 2024 |
Chen F, Onkar S, Zou J, Li Y, Arbore H, Maley S, Tseng G, Lucas P, Bruno T, Vignali D, Foldi J, Balic M, Lee AV, Oesterreich S. Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast Cancer. Research Square. PMID 39184073 DOI: 10.21203/rs.3.rs-4579052/v1 |
0.158 |
|
| 2012 |
Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nature Immunology. 13: 722-8. PMID 22814351 DOI: 10.1038/Ni.2366 |
0.156 |
|
| 2010 |
Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunology. 11: 70-5. PMID 19898473 DOI: 10.1038/Ni.1819 |
0.155 |
|
| 2012 |
Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA. Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35. Diabetes. 61: 1519-26. PMID 22427377 DOI: 10.2337/db11-0784 |
0.146 |
|
| 2012 |
Jones LL, Chaturvedi V, Uyttenhove C, Van Snick J, Vignali DA. Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Molecular Immunology. 51: 234-44. PMID 22487722 DOI: 10.1016/J.Molimm.2012.03.025 |
0.141 |
|
| 2004 |
Arnold PY, Burton AR, Vignali DA. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. Journal of Immunology (Baltimore, Md. : 1950). 173: 3103-11. PMID 15322170 |
0.14 |
|
| 2005 |
Szymczak AL, Vignali DA. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opinion On Biological Therapy. 5: 627-38. PMID 15934839 DOI: 10.1517/14712598.5.5.627 |
0.136 |
|
| 2008 |
Matsuzawa A, Tseng PH, Vallabhapurapu S, Luo JL, Zhang W, Wang H, Vignali DA, Gallagher E, Karin M. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science (New York, N.Y.). 321: 663-8. PMID 18635759 DOI: 10.1126/Science.1157340 |
0.131 |
|
| 2010 |
Vignali DA. CD4 on the road to coreceptor status. Journal of Immunology (Baltimore, Md. : 1950). 184: 5933-4. PMID 20483776 DOI: 10.4049/jimmunol.1090037 |
0.131 |
|
| 2008 |
Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H, Vignali DA, Bergsagel PL, Karin M. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nature Immunology. 9: 1364-70. PMID 18997792 DOI: 10.1038/ni.1678 |
0.109 |
|
| 2008 |
Wang H, Matsuzawa A, Brown SA, Zhou J, Guy CS, Tseng PH, Forbes K, Nicholson TP, Sheppard PW, Häcker H, Karin M, Vignali DA. Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin. Proceedings of the National Academy of Sciences of the United States of America. 105: 20197-202. PMID 19091944 DOI: 10.1073/pnas.0810461105 |
0.109 |
|
| 2005 |
Osborn MJ, Panoskaltsis-Mortari A, McElmurry RT, Bell SK, Vignali DA, Ryan MD, Wilber AC, McIvor RS, Tolar J, Blazar BR. A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 569-74. PMID 15964244 DOI: 10.1016/J.Ymthe.2005.04.013 |
0.106 |
|
| 2013 |
Herold KC, Vignali DA, Cooke A, Bluestone JA. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nature Reviews. Immunology. 13: 243-56. PMID 23524461 DOI: 10.1038/Nri3422 |
0.099 |
|
| 2021 |
Cruz T, Jia M, Sembrat J, Tabib T, Agostino N, Bruno TC, Vignali D, Sanchez P, Lafyatis R, Mora AL, Benos P, Rojas M. Reduce Proportion and Activity of NK Cells in the Lung of Idiopathic Pulmonary Fibrosis Patients. American Journal of Respiratory and Critical Care Medicine. PMID 34077698 DOI: 10.1164/rccm.202012-4418LE |
0.096 |
|
| 2016 |
Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH, Kang HC, Zhang J, Xu J, Chen R, Park H, ... ... Vignali DA, et al. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science (New York, N.Y.). 353. PMID 27708076 DOI: 10.1126/Science.Aah3374 |
0.087 |
|
| 2013 |
Vignali DA. Interview: immunotherapeutic manipulation of the tumor microenvironment. Immunotherapy. 5: 1279-81. PMID 24283836 DOI: 10.2217/imt.13.135 |
0.076 |
|
| 2012 |
Turnis ME, Korman AJ, Drake CG, Vignali DA. Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more. Oncoimmunology. 1: 1172-1174. PMID 23170269 DOI: 10.4161/onci.20593 |
0.075 |
|
| 2012 |
Szymczak-Workman AL, Vignali KM, Vignali DA. Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harbor Protocols. 2012: 199-204. PMID 22301656 DOI: 10.1101/pdb.ip067876 |
0.07 |
|
| 2012 |
Szymczak-Workman AL, Vignali KM, Vignali DA. Verification of 2A peptide cleavage. Cold Spring Harbor Protocols. 2012: 255-7. PMID 22301658 DOI: 10.1101/pdb.prot067892 |
0.059 |
|
| 2011 |
Megas C, Hatzivassiliou EG, Yin Q, Marinopoulou E, Hadweh P, Vignali DA, Mosialos G. Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation. Cellular Signalling. 23: 772-7. PMID 21185369 DOI: 10.1016/j.cellsig.2010.12.004 |
0.055 |
|
| 2018 |
El-Bouri WK, Vignali D, Iliadi K, Bulters DO, Marchbanks RJ, Birch AA, Simpson DM. Quantifying the contribution of intracranial pressure and arterial blood pressure to spontaneous tympanic membrane displacement. Physiological Measurement. PMID 29999499 DOI: 10.1088/1361-6579/aad308 |
0.048 |
|
| 2012 |
Szymczak-Workman AL, Vignali KM, Vignali DA. Generation of 2A-linked multicistronic cassettes by recombinant PCR. Cold Spring Harbor Protocols. 2012: 251-4. PMID 22301657 DOI: 10.1101/pdb.prot067884 |
0.046 |
|
| 2021 |
Bain W, Yang H, Shah FA, Suber T, Drohan C, Al-Yousif N, DeSensi RS, Bensen N, Schaefer C, Rosborough BR, Somasundaram A, Workman CJ, Lampenfeld C, Cillo AR, Cardello C, ... ... Vignali DA, et al. COVID-19 versus Non-COVID ARDS: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers and Clinical Outcomes. Annals of the American Thoracic Society. PMID 33544045 DOI: 10.1513/AnnalsATS.202008-1026OC |
0.033 |
|
| 2018 |
Campbell-Bell CM, Birch AA, Vignali D, Bulters D, Marchbanks RJ. Reference intervals for the evoked tympanic membrane displacement measurement: a non-invasive measure of intracranial pressure. Physiological Measurement. 39: 015008. PMID 29239860 DOI: 10.1088/1361-6579/aaa1d3 |
0.018 |
|
| Hide low-probability matches. |